Exhibitors and Sponsors
Silver Corporate Sponsorship:
|
Taylor&Francis, also including Dove Press, publishes vital research across medicine, health, and pharmaceutical science. Research articles are assessed by independent peer reviewers for quality, validity, and relevance. Many journals in our medical portfolio are indexed in the Science Citation Index, Science Citation Index Expanded, Scopus, and MEDLINE. Like you, we value high visibility and timely publication, and offer a range of open access and accelerated publication options to help you achieve your publication goals. Amazon’s Alexa service ranks our platform, Taylor&Francis Online, among the world’s most-visited academic journals publishing platforms so you can be confident that your work will reach the right audience at the right time. |
Conference Sponsors:
Certara Insight is a dynamic and talented company with regulatory expertise at the core of our business. Our vision is to be the first choice for medical writing excellence. Clear, concise regulatory documentation is critical to the success of any drug development programme. As a specialist writing provider with a proven track record, our wealth of experience in this area ensures smooth progress through submission to approval. We always strive to provide accuracy, consistency and clarity. For our clients it means support from a reliable, flexible and highly qualified team who deliver on time and budget. As part of Certara, we are working to increase our regulatory capabilities in the UK and Europe, with the added benefit of access to the latest developments in AI technology. |
Evidera, a PPD business, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products. We help companies generate the evidence needed to optimize the market access and commercial potential of their products.
We provide integrated and tailored scientific expertise and global operational capabilities. Our offerings include interventional studies, real-world evidence, data analytics, patient-centered research, epidemiological studies, modeling and simulation, literature reviews and evidence synthesis, market access consulting and communications, and medical writing.
Evidera has approximately 750 employees, including epidemiologists, health economists, outcomes researchers, market access consultants, and operational staff, representing over 45 nationalities in locations around the world. Our scientific and consulting staff are methodological and thought leaders who have contributed to hundreds of submissions to payers and regulators and have published more than 2,400 peer-reviewed articles dating back over 30 years.
DACHS delivers unique document management solutions and services to meet demanding pharma regulatory requirements.
OnStyle as a MS Word add-in:
OnTrack PDF Validator as a web-based service
Spend your time on content creation and rely on our extremely powerful tools to produce high-quality submission-ready documents. Look no further. Meet us to get access to our solutions that may be a game changer for your medical writer career. |
At Trilogy, medical writing is our passion. As specialists in clinical regulatory documentation, we provide a service that is more than just writing. Our writers are integral parts of our clients’ teams: proactively planning, coordinating and writing their clinical documents to meet timelines, with a readability that reduces the time for review and approval. We have been helping pharmaceutical companies and clinical research organizations of all sizes, worldwide, to streamline their documentation processes for 17 years – either as support on a one-off document or the entire clinical development program. Trilogy currently has more than 50 writers, who are located in Trilogy’s 4 offices: Frankfurt, Germany (HQ); Cambridge, UK; Carmel, Indiana and Durham, North Carolina, US. We pride ourselves on our “dedicated team” approach when developing documents, which greatly reduces the time needed for production and ensures much greater levels of continuity throughout an entire development program. |